Stay updated with breaking news from Drug approved. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
people, including a 9-year-old. they say a tip led to his arrest. also happening today, the fed is expected to raise interest rates again. the big question, though, is whether the fed chair, jay powell, signals that a pause is to come. also, the biden administration now signing off on sending 1,500 troops to the southern border ahead of an expected surge in migrants. and the u.s. announced a new immigration deal with mexico aimed at deterring border crossings. and new and promising data just released on an alzheimer s treatment. details about the drug the company says significantly slows cognitive and functional decline. and the new york times reports that said, quote, it s not how white men fight. new information on how that text may have contributed to his firing. cnn this morning starts right now. we do begin with the texas massacre suspect accused of gunning down five of his neighbors. he is now under arrest after a huge manhunt. the fbi says it received ....
Brain, this is what this drug does, starts to get removed really significantly. but that patient on the bottom, you can see those yellow areas of the brain are still really present. that is showing that they have these plaque buildups that stay there and this is contributing to the course of alzheimer s disease. what this study showed is by successfully removing that plaque, you can slow the course of the disease in this case by 35% on average. there has been so much hope and so much disappointment in really well-known alzheimer s drugs. and the expense there have been big fights in government over the expense of these drugs for older patients. how much do we have any sense of how much of a cost? would it be covered by medicare, medicaid? that is the key question. right now, there is a drug approved, but it is not covered broadly by medicare. and of course, this is a population that requires medicare coverage. that drug costs more than $26,000 a year. we don t yet know where li ....
Takeda's EXKIVITY® (mobocertinib) Receives Approval from the NMPA of China, Becoming the First and Only Therapy Available for Patients with EGFR Exon20 Insertion+ NSCLC streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
How Exercise May Help Keep Our Memory Sharp nytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nytimes.com Daily Mail and Mail on Sunday newspapers.
Seeking Early Signals of Dementia in Driving and Credit Scores nytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nytimes.com Daily Mail and Mail on Sunday newspapers.